BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
BostonGene has raised $150.0M in total funding. The most recent round was Series B. The last funding was announced in April 2022.
BostonGene's investors include NEC Corporation, Japan Industrial Partners, Impact Investment Capital.
BostonGene is headquartered in Waltham, United States.
BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
BostonGene is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BostonGene — Funding & Investors." VCBacked, April 6, 2022, https://www.vcbacked.co/company/bostongene. Accessed September 30, 2026.
VCBacked. (2022). BostonGene — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bostongene
{{cite web |title=BostonGene — Funding & Investors |url=https://www.vcbacked.co/company/bostongene |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated